In calling for a public health campaign to promote a brain-healthy lifestyle, an Oxford Health Policy Forumreport says people in middle age have a 10- to 20-year window of opportunity to potentially reduce the risk of developing neurodegenerative diseases such as Parkinsons (PD), or to delay progression. The process of neurodegeneration begins many years before symptoms appear, and it may take years for an at-risk individual to progress through the presymptomatic and prodromal disease phases until a clinical diagnosis can be made, the reports executive summary said. Continue reading →

PALO ALTO, Calif.--(BUSINESS WIRE)--Inscopix today announced a new research effort that leverages its brain mapping platform and single-cell transcriptomics for a more nuanced understanding of Parkinsons disease (PD) and identification of novel targets for therapeutic development. The research will be conducted in collaboration with Dr Continue reading →

A whopping percentage of adults have come across situations that resulted in neck pains. Since your neck is the most vulnerable body part, neck pains can result in muscle straining, arthritis, injury, and other serious diseases (may be Parkinsons too!). Having persistent neck pain is never a good thing! Whether you are a working person or homemaker, neck pain is a common condition that you think can be treated with pain reliving sprays or ointments.But now, no more! You should always consult with a doctor to know the cause of the pain! This will also determine how the treatment should be carried forward Continue reading →

Global Parkinsons Disease Treatment Market 2019-2025 Overview The Parkinsons disease treatment market growth was driven because of increase in the geriatric population and the rise in the occurrence of the Parkinsons disease and the funding for research. Global Parkinsons disease treatment market is anticipated to experience the substantial growth during the forecast period. Growth in the occurrence of the Parkinsons diseases is projected to supplement the growth of global Parkinsons disease treatment market in the coming future Continue reading →

AMA Research added a comprehensive research document of 200+ pages on Parkinsons Disease Treatment market with detailed insights on growth factors and strategies. The study segments key regions that includes North America, Europe, Asia-Pacific with country level break-up and provide volume* and value related cross segmented information by each country. Some of the important players from a wide list of coverage used under bottom-up approach are GSK (United Kingdom),Merck (United States),Novartis AG (Switzerland),Teva (Israel),Boehringer Ingelheim (Germany),Impax Laboratories (United States),Abbvie (United States),Valeant Pharmaceuticals (Canada),Lundbeck (Denmark),Sun Pharma (India) Request a sample report @ https://www.advancemarketanalytics.com/sample-report/33874-global-and-regional-parkinsons-disease-treatment-market Parkinsons disease is a type of chronic and progressive movement disorder that includes malfunction and death of vital nerves cells in the brain, termed as neurons. Continue reading →